Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Monitoring circulating progesterone (P4) concentration is an important component of basic and applied reproduction research and clinical settings. IMMULITE® 2000 XPi (Siemens) is a newly upgraded fully automated immunoassay system marketed for human use to measure concentrations of different analytes including P4. Our objective was therefore to characterize the analytical performance of the IMMULITE® 2000 XPi P4 immunoassay across the reportable range in ovine serum. This validation of analytical performance included determining (1) linearity, (2) precision through within-run, and between-run coefficient of variation (CV) calculations, (3) accuracy through bias calculations for spiking-recovery bias and interlaboratory (range and average based) bias for two laboratories across the reportable range (0.2−40 ng/mL). The average within-run and between-run precision (CV%) across the reportable range of the IMMULITE® 2000 XPi P4 immunoassay for serum P4 concentration were both <5%, ranging between 2−8%. The average Observed Total Analytic Error (TEo) reported here for serum P4 concentration across the reportable range was ~30%, ranging from 14.8−59.4%, regardless of the considered bias. Based on these data we conclude that the automated IMMULITE® 2000 XPi P4 immunoassay provides a precise, accurate, reliable, and safe method for measuring P4 concentration ovine serum.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774115PMC
http://dx.doi.org/10.3390/ani12243534DOI Listing

Publication Analysis

Top Keywords

2000 xpi
16
immulite® 2000
12
reportable range
12
ovine serum
8
analytical performance
8
xpi immunoassay
8
within-run between-run
8
analytical validation
4
validation immulite
4
0
4

Similar Publications

Clinical evaluation of the ADVIA Centaur XPT chemiluminescent immunoassay for equine insulin measurement.

J Equine Vet Sci

September 2025

Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Av. Puerta de Hierro, s/n, 28040 Madrid, Spain.

Background: Insulin dysregulation is a key component of equine metabolic syndrome and is commonly assessed using basal insulin concentrations. Different analyzers may yield variable insulin results, limiting comparability.

Aims/objectives: To assess the analytical performance of the ADVIA Centaur XPT chemiluminescent immunoassay (CLIA) for equine insulin measurement and to establish adapted decision thresholds based on comparison with a previously used CLIA method.

View Article and Find Full Text PDF

Objective: To establish the de novo reference interval (RI) for urinary cortisol-to-creatinine ratio (UCCR) in healthy dogs (HDs) using the currently available chemiluminescent enzyme immunoassay antibody (Veterinary Cortisol; IMMULITE 2000 XPi; Siemens Healthineers) and to evaluate UCCR diagnostic performance in dogs with hypercortisolism (HC).

Methods: This was a retrospective, single-center, observational study. Stored urine samples from dogs with HC or diseases mimicking HC (DMHC) at the time of diagnosis were selected from July 2019 through November 2022.

View Article and Find Full Text PDF

Introduction: Cytomegalovirus (CMV) is a virus of the herpesviridae family. CMV infection is associated with increased morbidity and mortality in immunocompromised subjects such as hemodialysis patients and transplant recipients. The aim of our study was to determine the serological status of potential kidney recipients and donors in order to assess the risk of post-transplant CMV infection and disease.

View Article and Find Full Text PDF

Previously, radioimmunoassay (RIA) has been the only assay to measure insulin-like growth factor-1 (IGF-1) to diagnose hypersomatotropism (HS). Due to radiation concerns, availability, and the cost of IGF-1 RIA, validation of assays for automated analysers such as a chemiluminescent immunoassay (CLIA) is needed. The aim of this study was to validate a CLIA for measurement of feline IGF-1 (IMMULITE 2000 XPi, Siemens Medical Solutions Diagnostics, Malvern, PA, USA) compared to IGF1 RIA, establish reference interval (RI), and determine a cut-off value for diagnosis of HS in diabetic cats.

View Article and Find Full Text PDF

The measurement of the blood insulin concentration, and comparison to cut-offs, is essential in diagnosing insulin dysregulation, a common equine endocrinopathy. However, different insulin assays provide disparate results. We aimed to ease comparison between assays by compiling original and published data into a web app to convert insulin measurements from one assay to another.

View Article and Find Full Text PDF